AstraZeneca taps into AI firms to build cancer antibodies to replace chemotherapy.
. Generative AI-Built Cancer Antibodies will reportedly be worked on by AstraZeneca and Absci after signing a deal approximately worth $247 million, as reported by Reuters.
Thanksgiving day is just around the corner. However, the pandemic still makes it unsafe to have large gatherings. Here's how you can protect your family.